New insight into causes of rheumatoid arthritis

The Rheumatology Research Group at BHP founder member the University of Birmingham has established that a chemical messenger released by blood vessels instructs tissue cells to become aggressive and destroy joints, a classic symptom of rheumatoid arthritis. Rheumatoid arthritis is a disease in which tissues of the joint become inflamed and swollen. Exactly why synovial … Continue reading “New insight into causes of rheumatoid arthritis”

Rethinking the role of health and life sciences as a regional driver of post-COVID recovery

Dr John Williams, Managing Director of Birmingham Health Partners and Michael Lewis, Professor of Life Science Innovation, discuss the role of health and life sciences as a regional driver of post-COVID recovery.  Two years ago, Professors Richard Jones and James Wilsdon published the wide ranging Biomedical Bubble report that asked whether a policy and funding landscape … Continue reading “Rethinking the role of health and life sciences as a regional driver of post-COVID recovery”

UHB patients take part in promising coronavirus drug trial

A trial testing a drug known as SNG001 has been shown to significantly reduce the risk of patients who have COVID-19 developing severe disease, early results show. The Phase II SNG001 trial recruited 101 patients across the country, with 17 patients taking part at University Hospitals Birmingham, making the Trust the third highest recruiter nationally. … Continue reading “UHB patients take part in promising coronavirus drug trial”

Preparing for life sciences post-COVID19

Medilink, the industry association for the Life Sciences & Medical Technology Sector in the Midlands, is pleased to present a series of free online events to help steer our region’s life sciences businesses through COVID-19 recovery – providing specialist support to boost the region’s economic output from life sciences and medical technology by overcoming barriers … Continue reading “Preparing for life sciences post-COVID19”

How Birmingham is helping with SARS-CoV-2 genomics

Nick Loman is Professor of Microbial Genomics and Bioinformatics in the Institute of Microbiology and Infection, and since March has been leading the team at the University of Birmingham who are part of the COVID-19 Genomics UK Consortium. Here, he explains how this team is working in the lab to help us understand the spread of … Continue reading “How Birmingham is helping with SARS-CoV-2 genomics”